Wealth Enhancement Advisory Services »

Axsome Therapeutics shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 19k 79.80
2023-12-31 $1.5M 19k 79.59

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Moment (IMTM)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Alps Etf Tr Smith Core Plus (SMTH)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
American Centy Etf Tr Us Large Cap Vlu (AVLV)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Axsome Therapeutics

Vanguard Group
Fairmount Funds Management
BVF
Citadel Advisors
Perceptive Advisors
RA Capital Management
Millennium Management
Point72 Asset Management
Alethea Capital Management
Bellevue Group
Partner Fund Management
Avidity Partners Management
Boxer Capital
Eventide Asset Management
Tang Capital Management

View all funds holding Axsome Therapeutics